Biological Age as a New Risk Factor for Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus

For the prevention of diabetic retinopathy, it is important to study risk factors, among which, along with the duration of type 2 diabetes mellitus, the level of glycemia, obesity, chronological age is indicated, but biological age is not considered as a potential risk factor, although biological ag...

Full description

Saved in:
Bibliographic Details
Main Authors: N. M. Agarkov, O. L. Fabrikantov, I. V. Lev
Format: Article
Language:Russian
Published: Ophthalmology Publishing Group 2024-06-01
Series:Oftalʹmologiâ
Subjects:
Online Access:https://www.ophthalmojournal.com/opht/article/view/2371
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849687575499898880
author N. M. Agarkov
O. L. Fabrikantov
I. V. Lev
author_facet N. M. Agarkov
O. L. Fabrikantov
I. V. Lev
author_sort N. M. Agarkov
collection DOAJ
description For the prevention of diabetic retinopathy, it is important to study risk factors, among which, along with the duration of type 2 diabetes mellitus, the level of glycemia, obesity, chronological age is indicated, but biological age is not considered as a potential risk factor, although biological age more objectively than chronological characterizes pathological changes at the cellular level and processes apoptosis. Purpose: to study biological age as a new risk factor for diabetic retinopathy in patients with type 2 diabetes mellitus. 580 patients aged 45–59 years with diabetic retinopathy and type 2 diabetes mellitus, whose biological age was calculated according to the Voitenko V.P. et al. methodology, took part in the study on the basis of the S.N. Fedorov National medical research center “MNTK Eye Microsurgery”. The correspondence of biological and chronological age was established in 124 patients, the excess (acceleration) of the chronological biological age in 357 patients and the excess of the biological chronological age in 99 patients. In the subsequent analysis, the first two groups were considered. Among 45–59­year­old patients with type 2 diabetes mellitus, the incidence of diabetic retinopathy was 19.82 ± 1,32 cases per 100 examined, which is statistically significantly higher (p < 0.001) compared to patients of the same age with type 2 diabetes mellitus with a chronological biological age — 10.24 ± 1.51 cases per 100 examined. Significant differences in the compared groups were also revealed in the values of the chronological age of diagnosis of diabetic retinopathy in this endocrine disease — 47.69 ± 1.24 years in patients with accelerated biological age and 50.23 ± 0.92 years in patients with matching biological and chronological age (p < 0.01). The biological age of diagnosis of diabetic retinopathy, respectively, was 56.13 ± 0.83 years and 49.61 ± 1.11 years (p < 0.001). The difference in the development of diabetic retinopathy in patients 45–59 years old with type 2 diabetes mellitus by biological age was 6,52 ± 1,24 years among patients with accelerated biological age and 0.62 ± 0.09 years among patients with matching biological and chronological age (p < 0.001). Consequently, the acceleration of biological age is a significant and new risk factor for diabetic retinopathy in patients aged 45–59 years with type 2 diabetes mellitus.
format Article
id doaj-art-131acc8fd9084f478c9f3a236bb5e7f4
institution DOAJ
issn 1816-5095
2500-0845
language Russian
publishDate 2024-06-01
publisher Ophthalmology Publishing Group
record_format Article
series Oftalʹmologiâ
spelling doaj-art-131acc8fd9084f478c9f3a236bb5e7f42025-08-20T03:22:18ZrusOphthalmology Publishing GroupOftalʹmologiâ1816-50952500-08452024-06-0121234835310.18008/1816-5095-2024-2-348-3531152Biological Age as a New Risk Factor for Diabetic Retinopathy in Patients with Type 2 Diabetes MellitusN. M. Agarkov0O. L. Fabrikantov1I. V. Lev2Southwest State University; Belgorod State National Research University; Tambov branch of S. Fyodorov Eye Microsurgery Federal State InstitutionTambov branch of S. Fyodorov Eye Microsurgery Federal State InstitutionTambov branch of S. Fyodorov Eye Microsurgery Federal State InstitutionFor the prevention of diabetic retinopathy, it is important to study risk factors, among which, along with the duration of type 2 diabetes mellitus, the level of glycemia, obesity, chronological age is indicated, but biological age is not considered as a potential risk factor, although biological age more objectively than chronological characterizes pathological changes at the cellular level and processes apoptosis. Purpose: to study biological age as a new risk factor for diabetic retinopathy in patients with type 2 diabetes mellitus. 580 patients aged 45–59 years with diabetic retinopathy and type 2 diabetes mellitus, whose biological age was calculated according to the Voitenko V.P. et al. methodology, took part in the study on the basis of the S.N. Fedorov National medical research center “MNTK Eye Microsurgery”. The correspondence of biological and chronological age was established in 124 patients, the excess (acceleration) of the chronological biological age in 357 patients and the excess of the biological chronological age in 99 patients. In the subsequent analysis, the first two groups were considered. Among 45–59­year­old patients with type 2 diabetes mellitus, the incidence of diabetic retinopathy was 19.82 ± 1,32 cases per 100 examined, which is statistically significantly higher (p < 0.001) compared to patients of the same age with type 2 diabetes mellitus with a chronological biological age — 10.24 ± 1.51 cases per 100 examined. Significant differences in the compared groups were also revealed in the values of the chronological age of diagnosis of diabetic retinopathy in this endocrine disease — 47.69 ± 1.24 years in patients with accelerated biological age and 50.23 ± 0.92 years in patients with matching biological and chronological age (p < 0.01). The biological age of diagnosis of diabetic retinopathy, respectively, was 56.13 ± 0.83 years and 49.61 ± 1.11 years (p < 0.001). The difference in the development of diabetic retinopathy in patients 45–59 years old with type 2 diabetes mellitus by biological age was 6,52 ± 1,24 years among patients with accelerated biological age and 0.62 ± 0.09 years among patients with matching biological and chronological age (p < 0.001). Consequently, the acceleration of biological age is a significant and new risk factor for diabetic retinopathy in patients aged 45–59 years with type 2 diabetes mellitus.https://www.ophthalmojournal.com/opht/article/view/2371diabetic retinopathytype 2 diabetes mellituschronological agebiological agerisk factors for diabetic retinopathyophthalmological complications of type 2 diabetes mellitus
spellingShingle N. M. Agarkov
O. L. Fabrikantov
I. V. Lev
Biological Age as a New Risk Factor for Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus
Oftalʹmologiâ
diabetic retinopathy
type 2 diabetes mellitus
chronological age
biological age
risk factors for diabetic retinopathy
ophthalmological complications of type 2 diabetes mellitus
title Biological Age as a New Risk Factor for Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus
title_full Biological Age as a New Risk Factor for Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus
title_fullStr Biological Age as a New Risk Factor for Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus
title_full_unstemmed Biological Age as a New Risk Factor for Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus
title_short Biological Age as a New Risk Factor for Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus
title_sort biological age as a new risk factor for diabetic retinopathy in patients with type 2 diabetes mellitus
topic diabetic retinopathy
type 2 diabetes mellitus
chronological age
biological age
risk factors for diabetic retinopathy
ophthalmological complications of type 2 diabetes mellitus
url https://www.ophthalmojournal.com/opht/article/view/2371
work_keys_str_mv AT nmagarkov biologicalageasanewriskfactorfordiabeticretinopathyinpatientswithtype2diabetesmellitus
AT olfabrikantov biologicalageasanewriskfactorfordiabeticretinopathyinpatientswithtype2diabetesmellitus
AT ivlev biologicalageasanewriskfactorfordiabeticretinopathyinpatientswithtype2diabetesmellitus